Marco Vito Marino1,2, Salomone Di Saverio3, Mauro Podda4, Marcos Gomez Ruiz5, Manuel Gomez Fleitas6. 1. Department of Emergency and General Surgery, Azienda Ospedaliera Ospedali Riuniti "Villa Sofia-Cervello", Via Trabucco 180, 90146, Palermo, Italy. marco.vito.marino@gmail.com. 2. Department of Colorectal and General Surgery, Hospital Universitario Marqués de Valdecilla, Av. Valdecilla 25z, 39008, Santander, Spain. marco.vito.marino@gmail.com. 3. Cambridge Colorectal Unit, Addenbrooke'S University Hospital NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. 4. Department of General, Emergency and Minimally Invasive Surgery, Cagliari University Hospital "Policlinico D. Casula", SS 554 Km 4,500, 09142, Cagliari, Italy. 5. Department of Colorectal and General Surgery, Hospital Universitario Marqués de Valdecilla, Av. Valdecilla 25z, 39008, Santander, Spain. 6. Departamento de Innovación Y Cirugía Robótica, Hospital Universitario Marqués de Valdecilla, Av. Valdecilla 25, 39008, Santander, Spain.
Abstract
BACKGROUND: The ICG fluorescence properties are progressively gaining momentum in the HPB surgery. However, the exact impact of ICG application on surgical outcomes is yet to be established. METHODS: Twenty-five patients who underwent ICG fluorescence-guided robotic liver resection were case-matched in a 1:1 ratio to a cohort who underwent standard robotic liver resection. RESULTS: In the ICG group, six additional lesions not diagnosed by preoperative workup and intraoperative ultrasound were identified and resected. Four of the lesions were proved to be malignant. Despite the similar operative time (288 vs. 272 min, p = 0.778), the risk of postoperative bile leakage (0% vs. 12%, p = 0.023), R1 resection (0% vs. 16%, p = 0.019) and readmission (p = 0.023) was reduced in the ICG group compared with the no-ICG group. CONCLUSIONS: The ICG fluorescence is a real-time navigation tool which enables surgeons to enhance visualization of anatomical structures and overcome the disadvantages of minimally invasive liver resection. The procedure is not time-consuming, and its applications can reduce the postoperative complication rate in robotic liver surgery.
BACKGROUND: The ICG fluorescence properties are progressively gaining momentum in the HPB surgery. However, the exact impact of ICG application on surgical outcomes is yet to be established. METHODS: Twenty-five patients who underwent ICG fluorescence-guided robotic liver resection were case-matched in a 1:1 ratio to a cohort who underwent standard robotic liver resection. RESULTS: In the ICG group, six additional lesions not diagnosed by preoperative workup and intraoperative ultrasound were identified and resected. Four of the lesions were proved to be malignant. Despite the similar operative time (288 vs. 272 min, p = 0.778), the risk of postoperative bile leakage (0% vs. 12%, p = 0.023), R1 resection (0% vs. 16%, p = 0.019) and readmission (p = 0.023) was reduced in the ICG group compared with the no-ICG group. CONCLUSIONS: The ICG fluorescence is a real-time navigation tool which enables surgeons to enhance visualization of anatomical structures and overcome the disadvantages of minimally invasive liver resection. The procedure is not time-consuming, and its applications can reduce the postoperative complication rate in robotic liver surgery.
Authors: Cherie P Parungo; Shunsuke Ohnishi; Sang-Wook Kim; Sunjee Kim; Rita G Laurence; Edward G Soltesz; Frederick Y Chen; Yolonda L Colson; Lawrence H Cohn; Moungi G Bawendi; John V Frangioni Journal: J Thorac Cardiovasc Surg Date: 2005-04 Impact factor: 5.209
Authors: Moritz Koch; O James Garden; Robert Padbury; Nuh N Rahbari; Rene Adam; Lorenzo Capussotti; Sheung Tat Fan; Yukihiro Yokoyama; Michael Crawford; Masatoshi Makuuchi; Christopher Christophi; Simon Banting; Mark Brooke-Smith; Val Usatoff; Masato Nagino; Guy Maddern; Thomas J Hugh; Jean-Nicolas Vauthey; Paul Greig; Myrddin Rees; Yuji Nimura; Joan Figueras; Ronald P DeMatteo; Markus W Büchler; Jürgen Weitz Journal: Surgery Date: 2011-02-12 Impact factor: 3.982
Authors: Anne-Sophie Mehdorn; Florian Richter; Katharina Hess; Jan Henrik Beckmann; Jan-Hendrik Egberts; Michael Linecker; Thomas Becker; Felix Braun Journal: J Clin Med Date: 2022-06-19 Impact factor: 4.964
Authors: Anne-Sophie Mehdorn; Jan Henrik Beckmann; Felix Braun; Thomas Becker; Jan-Hendrik Egberts Journal: J Clin Med Date: 2021-01-25 Impact factor: 4.241
Authors: Wang Jianxi; Zou Xiongfeng; Zheng Zehao; Zhao Zhen; Peng Tianyi; Lin Ye; Jin Haosheng; Jian Zhixiang; Wang Huiling Journal: Front Oncol Date: 2022-07-19 Impact factor: 5.738
Authors: Thomas Wendler; Fijs W B van Leeuwen; Nassir Navab; Matthias N van Oosterom Journal: Eur J Nucl Med Mol Imaging Date: 2021-06-29 Impact factor: 9.236